Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04434378 · ClinicalTrials.gov registry record · Phase 4
Tamsulosin to Prevent Postoperative Urinary Retention in Laparoscopic Inguinal Hernia Repair
A Phase 4 study, sponsored by Jewish Hospital, Cincinnati, Ohio.
- Terminated
- Registry status
- Phase 4
- Development phase
- 170
- Enrollment target
NCT04434378 is a Phase 4 study that was terminated before completion, run by Jewish Hospital, Cincinnati, Ohio. The registered enrollment target is 170 participants.
The verdict
NCT04434378, a Phase 4 study, was terminated before completion, sponsored by Jewish Hospital, Cincinnati, Ohio.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 170 participants
- Enrollment target
Study Summary
To investigate the effect of tamsulosin on the development of post-operative urinary retention (PUR) after elective laparoscopic inguinal hernia repair (LIHR). This will be accomplished by administering a pre-operative dose of tamsulosin. The primary outcome is the rate of urinary retention necessitating straight catheterization or insertion of foley catheter prior to discharge.
Interventions
- DRUG Placebo
- DRUG Tamsulosin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2017-11-16 |
| Est. Completion | 2020-02-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04434378
The ClinicalTrials.gov registry entry for NCT04434378 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jewish Hospital, Cincinnati, Ohio, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04434378 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04434378 about?
NCT04434378 is a clinical study titled "Tamsulosin to Prevent Postoperative Urinary Retention in Laparoscopic Inguinal Hernia Repair". To investigate the effect of tamsulosin on the development of post-operative urinary retention (PUR) after elective laparoscopic inguinal hernia repair (LIHR). This will be accomplished by administering a pre-operative dose of tamsulosin. The primary outcome is the rate of urinary retention necessit...
What is the current status of trial NCT04434378?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 170 participants. The study started on 2017-11-16. Estimated completion is 2020-02-05.
What interventions are being tested in trial NCT04434378?
The interventions under investigation include: Placebo (DRUG), Tamsulosin (DRUG).
Who is sponsoring clinical trial NCT04434378?
This trial is sponsored by Jewish Hospital, Cincinnati, Ohio, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.